Celyad SA Gains 25%
Thu, May 19, 2022 at 05:30 PM
Celyad SA (CYAD:NASDAQ) rocketted at $1.93, a gain of 25%. The stock got featured on our News Catalysts scanner on Tue, May 17, 2022 at 05:22 PM in the 'MISCELLANEOUS' category. From Wed, May 04, 2022, the stock recorded 30.00% Up Days and 45.45% Green Days
The stock spiked on Fri, Dec 03, 2021 at $5.32 with a volume of 56M+.
About Celyad SA (CYAD:NASDAQ)
Celyad SA is a biopharmaceutical company. The company is engaged in stem cell-based therapies for the treatment of cardiovascular diseases. It is developing therapeutic therapies based on two distinct technology platforms in cardiology and oncology.
Top 10 Gainers:
- NeuroMetrix, Inc. (NURO:NASDAQ), 76.28%
- VivoPower International PLC (VVPR:NASDAQ), 46.3%
- BIT Mining Limited ADS (BTCM:NYSE), 28.05%
- AcelRx Pharmaceuticals, Inc. (ACRX:NASDAQ), 27.63%
- Pop Culture Group Co. Ltd (CPOP:NASDAQ), 27.59%
- Immix Biopharma Inc. (IMMX:NASDAQ), 25.38%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 25%
- Celyad SA (CYAD:NASDAQ), 25%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%
- Pineapple Holdings Inc Com (PEGY:NASDAQ), 24.2%